Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial

Nav

General Info

Geography

China (CHN)

Time period covered

01/2014 - 12/2015

Data type

Scientific literature

Keywords

Diarrhea, Diarrheal diseases, Rotavirus

Citation

Authors

Mo Z, Mo Y, Li M, Tao J, Yang X, Kong J, Wei D, Fu B, Liao X, Chu J, Qiu Y, Hille DA, Nelson M, Kaplan SS

Journal

Vaccine

Volume

Issue

Pages

5897-5904

Publication year

2017

Suggested citation

Mo Z, Mo Y, Li M, Tao J, Yang X, Kong J, Wei D, Fu B, Liao X, Chu J, Qiu Y, Hille DA, Nelson M, Kaplan SS. Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial. Vaccine. 2017; 35(43): 5897-5904.

DOI

10.1016/j.vaccine.2017.08.081

PMID

28935470

GHDx Entry last modified on: May 30, 2020

Header sites

Search form

Main menu

Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial

Nav